Buy O-PCE Pellets (10mg): Premium Research Product

Overview

O-PCE Pellets is the common abbreviation for 2-Oxo-PCE. It is also known scientifically as N-ethyldeschloroketamine or eticyclidone.

Like several other dissociative compounds, O-PCE belongs to the arycyclohexylamine family. It shares a close structural relationship with deschloroketamine (DCK) and methoxetamine (MXE). Forensic laboratories first identified O-PCE around 2016, when it appeared on the research chemical market as another alternative to ketamine and MXE.

Why Is O-PCE Sold as 10 mg Pellets?

Early research chemicals were commonly sold as loose powders. However, accurately measuring very small amounts proved difficult, which increased the risk of accidental overdoses.

To address this issue, some manufacturers began pressing compounds into small tablets or pellets. Although this format appears more convenient, it does not eliminate the risks.

Deceptive Potency

A 10 mg O-PCE pellet may sound like a small amount, but O-PCE is highly potent. The compound produces noticeable effects at doses of only 2 to 5 mg, making a 10 mg pellet a relatively strong amount.

Inconsistent Dosing

Because illicit manufacturers produce these pellets without pharmaceutical quality control, the amount of O-PCE can vary between pellets. For example, one pellet may contain less than the stated amount, while another may contain significantly more. These inconsistencies, often referred to as “hot spots,” make dosing unpredictable.

How O-PCE Affects the Brain

O-PCE acts primarily as an NMDA receptor antagonist.

By blocking NMDA receptors, it disrupts the activity of glutamate, an important neurotransmitter involved in learning, memory, and sensory processing. As a result, communication between the brain and the body becomes altered, producing dissociative effects.

Reports and toxicological observations commonly describe the following effects:

Profound dissociation – A strong feeling of detachment from the body and surrounding environment. At higher amounts, some individuals experience complete physical immobilisation, sometimes referred to as a “hole.”
Mental stimulation – Unlike ketamine, O-PCE may produce noticeable stimulation alongside dissociation. This combination can contribute to confusion, agitation, or manic behaviour in some individuals.
Long duration – Effects typically last 3 to 6 hours, while residual cognitive impairment or mental fog may continue into the following day.

Potential Health Risks

Because of its potency and long duration, O-PCE carries several significant health concerns.

Risk of Injury

Strong dissociative effects can reduce awareness of the surrounding environment. Consequently, individuals may become unable to respond appropriately to injuries or medical emergencies.

Psychological Effects

In addition, the combination of intense dissociation and mental stimulation may increase the likelihood of panic, paranoia, confusion, or temporary psychotic symptoms, particularly in susceptible individuals.

Possible Long-Term Toxicity

Furthermore, O-PCE shares structural similarities with ketamine. For this reason, healthcare professionals suspect that repeated exposure may carry similar risks of bladder and urinary tract damage, including ketamine-associated cystitis, although long-term human data remain limited.

Current Legal Status

Authorities throughout the UK and Europe have introduced restrictions on O-PCE because of its potency and associated public health concerns.

United Kingdom

Under the Misuse of Drugs Act 1971, O-PCE falls within the UK’s controls on arylcyclohexylamine compounds. As a result, unauthorized possession, production, and supply are criminal offences.

Europe

Across Europe, many countries also regulate O-PCE.

In Germany, the compound falls under the New Psychoactive Substances Act (NpSG), which restricts its use to authorised scientific and industrial research. Likewise, countries such as Sweden have introduced specific controls to prevent its unregulated distribution.

Summary

O-PCE is a highly potent arylcyclohexylamine dissociative that first emerged around 2016. It primarily acts by blocking NMDA receptors, producing prolonged dissociative effects and altered perception. Although 10 mg pellets may appear convenient, O-PCE remains highly potent, and inconsistent manufacturing can make dosing unpredictable. Because of its potential health risks and limited clinical research, authorities across the UK and Europe have introduced strict legal controls that restrict its use to authorised research settings.

where to find O-PCE Pellets – 10mg Athens

O-PCE Pellets – 10mg